← 治験一覧に戻る
アジア前立腺がん研究グループ(A-CaP研究)
基本情報
- NCT ID
- NCT02873013
- ステータス
- 招待制
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 20,000
- 治験依頼者名
- Japan Study Group of Prostate Cancer
概要
This study will target patients who have received a histopathological diagnosis of prostate cancer and who are undergoing treatment in various forms, including active PSA surveillance, surgical treatment, radiotherapy, endocrine therapy, and chemotherapy. The study will survey information about the patient at time of diagnosis, clinical staging, details of initial treatment, status of disease progression, and prognosis at the end point of the study. The purpose of the study is to clarify distribution of staging, the actual status of treatment choices and treatment outcomes.
対象疾患
Prostate Cancer
依頼者(Sponsor)
実施施設 (1)
The University of Tokyo
Tokyo, Meguro-ku, Japan